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ABSTRACT
Transcriptional repressor complexes containing
p130 and E2F4 regulate the expression of genes in-
volved in DNA replication. During the G1 phase of
the cell cycle, sequential phosphorylation of p130
by cyclin-dependent kinases (Cdks) disrupts these
complexes allowing gene expression. The Cdk in-
hibitor and tumor suppressor p27Kip1 associates with
p130 and E2F4 by its carboxyl domain on the pro-
moters of target genes but its role in the regulation
of transcription remains unclear. We report here that
p27Kip1 recruits cyclin D2/D3–Cdk4 complexes on the
promoters by its amino terminal domain in early and
mid G1. In cells lacking p27Kip1, cyclin D2/D3–Cdk4
did not associate to the promoters and phosphory-
lation of p130 and transcription of target genes was
increased. In late G1, these complexes were substi-
tuted by p21Cip1-cyclin D1–Cdk2. In p21Cip1 null cells
cyclin D1–Cdk2 were not found on the promoters and
transcription was elevated. In p21/p27 double null
cells transcription was higher than in control cells
and single knock out cells. Thus, our results clarify
the role of p27Kip1 and p21Cip1 in transcriptional reg-
ulation of genes repressed by p130/E2F4 complexes
in which p27Kip1 and p21Cip1 play a sequential role
by recruiting and regulating the activity of specific
cyclin–Cdk complexes on the promoters.
INTRODUCTION
Cyclin-dependent kinases (Cdks) are serine/threonine ki-
nases characterized by their need for associating with a reg-
ulatory subunit, the cyclin that modifies Cdk conformation
and provides domains necessary for catalytic activity (1).
This family of kinases includes 20 members named Cdk1
through Cdk20 (2). Many members of this family, includ-
ing Cdk4, Cdk6, Cdk2 and Cdk1, are involved in cell-cycle
regulation (3). Cdk4, Cdk6 and Cdk2 regulate progression
through the G1 phase although additionally, Cdk2 also reg-
ulates S phase. Finally, Cdk1 regulates mitosis. Binding
of Cdks to specific cyclins confers a functional specializa-
tion to each complex (3). In response to mitogenic stim-
uli, the synthesis of the D-type cyclins is induced in early–
mid G1 phase. These cyclins associate with Cdk4 and Cdk6,
forming complexes that phosphorylate and inactivate mem-
bers of the retinoblastoma family of pocket proteins (pRb,
p107 and p130) (4). These adaptor proteins form complexes
with E2Fs that repress transcription. Phosphorylation of
pocked proteins by cyclin D-Cdk4/6 primes them for fur-
ther phosphorylation byCdk2 at other sites (5). These phos-
phorylations inactivate the pocket proteins resulting in de-
repression of multiple genes encoding for proteins required
for DNA replication (S phase) or mitosis. In addition to
the regulation by cyclins, Cdk activity is also regulated by
other mechanisms that include phosphorylation of specific
amino acid residues, acetylation and binding to proteins
called Cdk-inhibitors (CKIs) (1,2,6,7).
Two families of CKIs have been described. One is the
Cip/Kip family that includes p21Cip1 (p21), p27Kip1 (p27)
and p57Kip2 (p57) that associate with most cyclin–cdk com-
plexes (8). The second is the INK4 family that includes
p15INK4B, p16 INK4A, p18 INK4C and p19 INK4D that specif-
ically acts on Cdk4 and Cdk6 (9). All members of the
Cip/Kip family of CKIs interact with both cyclin and Cdk
subunits by two specific sequences in the Kinase Inhibitory
Domain (KID), included in the NH2-region. The mecha-
nism of inhibition consists in introducing a portion of the
Cdk-binding domain into the catalytic center of the kinase,
thus preventing interaction of the CdkwithATP (10). Inter-
estingly, it has been shown that the specific phosphorylation
of two tyrosine residues of p27 (Y74 and Y88) in the NH2
domain, by members of the Src tyrosine kinase family, in-
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duces a conformational change thatmodifies the interaction
of p27 with the catalytic center of the Cdk (11–13) induc-
ing a partial activation of the kinase (14). Thus, under these
circumstances cyclin–Cdk complexes might be partially ac-
tive despite its association with p27. Similarly, p21 can be
phosphorylated at Y76 (that is equivalent to Y88 in p27)
by Src family members. This phosphorylation also reduces
the inhibitory capability of p21 and as a consequence the
cyclin–Cdk complexes associatedwithY76-phosphorylated
p21 are partially active (15).
The carboxyl moieties of p27 and p21 are considered in-
trinsically disordered domains that can adopt different con-
formations depending on the protein partners that associate
with these regions (16). This characteristic probably under-
lies the large spectra of cellular functions that can be per-
formed by Cip/Kip proteins. Among these functions there
is the regulation of transcription. Data from ChIP-on-chip
revealed that p27 associates with specific gene promoters
(p27-target genes, p27-TGs) (17). The analysis of these pro-
moters indicated that they are enriched with sequences that
interact with E2F4. Subsequent analysis revealed that p27
directly interacts with p130 andE2F4 by its carboxylmoiety
and that it acts as a transcriptional co-repressor (17). p21 is
also involved in transcriptional regulation. It has been re-
ported to behave as a transcriptional repressor by associ-
ating with a number of transcription factors such as E2Fs,
Myc, NRf2, CBP and STAT3 among others (18–20).
Interestingly, two recent papers demonstrated that p27
(21) and p21 (22) regulate the expression of Sox2. These
reports describe that p27 and p21 associate with the same
Sox2-SRR2 enhancer and that their association represses
the expression of Sox2. In the case of p27 repression was
mediated by association with p130/E2F4 complexes. Even
though in the case of p21 the participation of p130/E2F4
complexes has not been studied, these results suggest that
p27 and p21 can regulate Sox2 expression by similar mech-
anisms on the same regulatory region of the chromatin.
We report here that p27 and p21 collaborate in the
transcriptional regulation of p130/E2F4-dependent genes
during cell cycle progression. Specifically, we demonstrate
that on the promoters of specific target genes (Aurka and
Med18), p27 recruits cyclin D2/D3–Cdk4 complexes nec-
essary for the phosphorylation of p130 in mid G1. Sub-
sequently, these complexes are substituted by p21-cyclin
D1–Cdk2 complexes needed for further phosphorylation of
p130 in late G1, hence inducing the full transcription of tar-
get genes. Thus, p27 and p21 located on the promoters play
a key role in controlling the timing of gene transcription in
G1 and in the subsequent progression through the cell di-
vision cycle by recruiting specific cyclin–Cdk complexes to
these promoters.
MATERIALS AND METHODS
Cell culture and lentiviral infection
Mouse embryonic fibroblasts (MEFs) were cultured in
DMEM (Dulbecco’s modified Eagle Medium) supple-
mented with 10% fetal bovine serum whereas NIH3T3 cells
were cultured in DMEMwith 10% donor bovine serum. In
addition, all cell lines were supplemented with 2 mM L-
Glutamine, 1% non-essential amino acids, 1 mM pyruvic
acid, 50 U/ml penicillin and 50 g/ml streptomycin. Cul-
tures were maintained at 37oC and 5% CO2. p27 KO or p21
KO MEFs were infected with the lentiviral plasmid pLV-
Ires-GFP containing full length p27 or p21. The protocol
for viral particles production and cell infections has been
described elsewhere (23). Forty-eight hours after infection,
cells were serum deprived for 3 days. Then, they were col-
lected and subjected to western blot (WB), RNA isolation
and qPCR analysis.
Cell synchronization
MEFs were maintained in serum free medium for 72 h
whereas NIH3T3 cells were serum starved for 48 h. Ac-
tivation of proliferation was induced by serum addition.
Cells were collected at several times: at 6 h (NIH3T3) or
8 h (MEFs) that correspond to mid- G1 phase and at 12
h (NIH3T3) or 18 h (MEFs) corresponding to G1/S phase
transition. Cell synchronization was monitored by flow cy-
tometry of propidium iodide-stained cells. The cell cycle
timings upon serum stimulation in p27−/−, p21−/− and
DKO (p21 and p27 null cells)–MEFs were similar to that of
wild-type (WT) MEFs (24). Thus, cells from these different
cultures were collected at the same times that WT-MEFs
Flow cytometry analysis
Cells were fixed with 70% cold ethanol for 2 h at 4oC,
washedwith phosphate buffered saline (PBS) and incubated
with 20 g/ml of propidium iodide and 200 g/ml RNase
for 30 min at room temperature. Analysis of DNA content
was carried out in a Becton Dickinson FACS Calibur. Data
were analyzed with the WinMDI 2.9 software.
Immunoprecipitation
NIH3T3 cells and MEFs were scraped and washed twice
with PBS. Pellets were lysed in 2 ml of immunoprecipita-
tion (IP) buffer (PBS containing 0.5% Triton X-100, 1 mM
EDTA, 100 M sodium orthovanadate, 0.25 mM phenyl-
methylsulfonyl fluoride, complete protease inhibitor mix-
ture by Roche Applied Science and 1/25 vol of DNAse I).
Cell lysates were incubated on ice for 30 min and then cen-
trifuged at 3000 rpm at 4◦C for 5min. Protein concentration
was determined by Bradford protein assay using Bradford
reagent (BioRad). Thirty microgram of protein extract was
kept as input sample and 1 mg of total protein was incu-
bated overnight with 2 g of antibody. Antibodies used for
IP were the same than those used for chromatin IP (ChIP)
experiments. Magnetic beads (Dynabeads, Invitrogen) were
added and samples were incubated in rotation for 2 h at 4oC.
Beads were washed five times with lysis buffer, eluted with
0.1 M Citrate pH 2.5 and boiled in Laemmli buffer for WB
analysis. As a control, lysates were incubated with irrelevant
IgG.
ChIP
Cells were grown to confluence and synchronized in qui-
escence or at different times of G1 phase. ChIP assays
were performed as previously described (25). Briefly, cells
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were lysed and chromatin from cross-linked cells was soni-
cated. Chromatin was incubated with 2.5–5 g of antibod-
ies against p27 (sc-528, Santa Cruz), p21 (sc-397), cyclin
D1 (sc-246), cyclin D2 (sc-181), cyclin D3 (sc-182), Cdk4
(sc-260) or Cdk2 (sc-6248) in RIPA buffer, adding 20 l of
Magna ChIP Protein A magnetic beads (Millipore). Sam-
ples were incubated in rotation overnight at 4oC. Beads
were washed with low salt buffer, high salt buffer, LiCl
buffer and TE buffer. Subsequent elution and purification
of the immunoprecipitated DNA–proteins complexes was
performed using the IPure kit (Diagenode) according to
manufacturer’s protocol. Samples were analyzed by quanti-
tative PCR (qPCR). Primer sequences used for qPCR were
listed in Supplementary Table S1.
RNA extraction, reverse transcription-PCR and qPCR for
gene expression analysis
Total RNA from MEFs was extracted using High Pure
RNA Isolation kit (Roche). cDNA was obtained by reverse
transcription-PCR from 1 g of RNA using SuperScript
ViLO cDNA synthesis (Invitrogen) according to manufac-
turer’s instructions. Gene expression was analyzed by real-
time qPCRusing LightCycler 480 SYBRgreen Imastermix
(Roche), corrected by actin or GAPDH expression and ex-
pressed as relative units. Primer sequences used for qPCR
were listed in Supplementary Table S1.
WB antibodies
Antibodies against cyclin D1 (sc-246), cyclin D2 (sc-181),
cyclin D3 (sc-182), Cdk2 (sc-163), Cdk4 (sc-260) and p21
(sc-6246) were purchased from Santa Cruz. p27 antibody
(610242 BD) was purchased from BD Transduction Labo-
ratories. Actin antibody (0869100) was obtained from MP
Biomedicals. p130-phospho antibody (2272–1) was pur-
chased from Epitomics and tubulin antibody (T5192) was
obtained from Sigma-Aldrich.
RESULTS
p27 associates with the promoters of p27-target genes in early
and mid G1 phase
We first defined the timing of cell cycle progression in
NIH3T3 cells. Cells were serum starved for 48 h and pro-
liferation was induced by serum addition. As shown in Fig-
ure 1A, S phase started at 6 h and maximal DNA synthe-
sis was at 15 h. Cell cycle progression analysis in MEFs re-
vealed that DNA replication started at 8 h being the max-
imal DNA synthesis at 24 h (Figure 1B). Once timing was
defined, we studied the association of p27 with the promot-
ers of two p27-TGs, Aurka andMed18 (17), by ChIP at dif-
ferent times after proliferative activation of NIH3T3 cells
andMEFs. We selected the times corresponding to G0 (0 h)
mid G1 (6 h for NIH3T3 and 8 h for MEFs) and late G1 (12
h for NIH3T3 and 18 h for MEFs). Results revealed that
in NIH3T3 cells the association of p27 with the promoters
was high in G0 and mid G1 and significantly decreased in
late G1 (Figure 1C and D). Similar results were observed in
control MEFS. In this case, p27−/−-MEFs were used as a
negative control (Figure 1E and F).
Differential association of D-type cyclins with the promoters
of p27 target genes
The levels of p27 and D-type cyclins at different times af-
ter proliferative activation ofNIH3T3 cells were determined
by WB. Figure 2A shows that the amount of p27 decreased
from quiescence till late G1 whereas that of cyclins D1, D2
and D3 increased during the same period of time. To ana-
lyze the association of p27 with the different D-type cyclins,
IP experiments using anti-p27 were performed. In G0, p27
associated with cyclinD2 andD3 but not with cyclinD1. At
6 h p27 associated with all three D-type cyclins and this as-
sociation increased in lateG1 (Figure 2A). Quantification of
three different experiments was represented in a graph (Fig-
ure 2B). The association of D-type cyclins with the p27-TG
promoters was then determined by ChIP. As shown in Fig-
ure 2C and D, cyclins D2 and D3 behave similarly. Their
association with the Aurka andMed18 promoters was high
in G0 and further increased in mid G1 to subsequently de-
crease in late G1. Conversely, the association of cyclin D1
with the promoters was quite different. It was low in qui-
escent cells, increased in mid G1 and was high in late G1
(Figure 2E). Figure 2F and G summarize the association
kinetics of p27 and cyclins D1, D2 and D3 with the pro-
moters in NIH3T3 cells.
p27 is necessary for the association of cyclins D2 and D3 with
the promoters of target genes
The similar association kinetics of cyclinsD2, cyclinD3 and
p27 (Figure 2F and G) suggested that p27 could play a role
in the interaction of these two D-type cyclins with the pro-
moters. Thus, we studied the binding of p27 with the D-
cyclins in MEFs by IP using anti-p27 antibodies. Results
revealed that in G0 p27 associates with all D-type cyclins
and that this association clearly increased in late G1. IPs in
p27−/− MEFs were performed as a negative control (Figure
3A). ChIP analysis in p27−/− MEFs versus control revealed
that the association of cyclin D2 (Figure 3B) and cyclin D3
(Figure 3C) with the promoters in early and mid G1 was
significantly reduced, indicating that p27 is responsible for
the recruitment of these cyclins to the promoters after mi-
togenic stimulus.
p27 is necessary for the association of Cdk4 with the promot-
ers of target genes
As D-type cyclins are the main partners of Cdk4 we an-
alyzed the interactions of this kinase with p27 and these
cyclins. In NIH3T3, Cdk4 levels remain more or less con-
stant during G1 and IP analysis revealed that the associa-
tion of p27 with Cdk4 was high during G0 and mid G1 but
decreased in late G1 (Figure 4A). ChIP studies of the asso-
ciation of Cdk4 to the p27-TG promoters in NIH3T3 cells
revealed that its association was high in G0, intermediate in
mid G1 and low in late G1 (Figure 4B). IP experiments in
MEFs showed that the association of p27 with Cdk4 was
similar to that observed in NIH3T3 (Figure 4C). We also
studied the interaction of Cdk4 with p27, cyclin D2 and cy-
clin D3 by IP in p27WT and p27−/− MEFs. These experi-
ments revealed that while the association of cyclin D2 and
D3 with Cdk4 was abundant in p27WT MEFs in early and
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Figure 1. Association of p27 with the promoters of target genes. Flow cytometry analysis of NIH3T3 cells (A) or MEFs (B) performed at different times
after proliferative activation. The association of p27 with the promoter of the Aurka (C) or Med18 genes (D) in NIH3T3 cells was analyzed by ChIP
using anti-p27 or without antibodies as a control. Results are the mean value ± SD of three independent experiments and are relative to the control. The
association of p27 with the promoter of the Aurka (E) or Med18 genes (F) in p27wt and p27KO MEFs was analyzed by ChIP using anti-p27 or without
antibodies as a control. Results are themean value± SD of three independent experiments and are relative to the control. Statistical analysis was performed
using the Student’s t-test. *P < 0.05, ***P < 0.001.
late G1, cyclin D2 andD3 binding to Cdk4 was significantly
reduced in p27-null MEFs, in agreement with p27 playing a
role of assembly factor for Cdk4/D-type cyclin complexes
(Figure 4D). Furthermore, ChIP analysis in p27WT versus
p27−/− MEFs revealed that in the absence of p27, the in-
teraction of Cdk4 with the promoters was strongly reduced
(Figure 4E) indicating that p27 is necessary for the recruit-
ment of Cdk4 to the promoters in G0 and mid G1.
The mutant p27CK− is not able to recruit cyclin D2/D3 and
Cdk4 on the promoters of target genes
To further confirm that p27 is responsible of the recruitment
of cyclinD2, cyclinD3 andCdk4 on the promoters of target
genes we performed ChIP analysis in MEFs from animals
whose p27WT has been substituted by the mutant p27CK−.
This mutant carries four point mutations in the KID do-
main that prevent its association with cyclins andCdks (26).
It has been previously reported that p27CK− is able to as-
sociate with the p27-TG promoters because the interaction
is performed by the COOH region (17). ChIP analysis per-
formed in p27CK− MEFs revealed that the association of
cyclin D2 (Figure 5A) and cyclin D3 (Figure 5B) to the pro-
moters was reduced in p27CK- cells at early and mid G1, as
observed in p27−/−-MEFs. These results confirm that p27
recruits cyclin D2 and D3 on the promoters via its KID do-
main.
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Figure 2. Differential association of D-type cyclins with the promoters of target genes. (A) The levels of p27 and D-type cyclins, at different times after
proliferative activation of NIH3T3 cells, were determined by WB (input). The association of p27 with the D-type cyclins was analyzed by IP using anti-
p27. IP using a non-specific IgG was used as a control. (B) Quantification of IP experiments. Results are the mean value of three independent experiments
and are relative to p27 levels. The association of cyclin D2 (C), cyclin D3 (D) and cyclin D1 (E) with the Aurka promoter (upper panels) or the Med18
promoter (bottom panels) in NIH3T3 cells was analyzed by ChIP using anti-p27 or without antibodies as a control. Results are the mean value ± SD of
three independent experiments and are relative to the control. Graphics showing the association kinetics of p27, cyclin D1, D2 and D3 to the Med18 (F)
and Aurka (G) promoters. Statistical analysis was performed using the Student’s t-test. **P < 0.01.
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Figure 3. p27 is required for the recruitment of cyclin D2 and D3 on the promoters of target genes in early and mid G1. (A) The association of p27 with
the D-type cyclins at different times after proliferative activation of MEFs was analyzed by IP using anti-p27. IP using a non-specific IgG was used as a
control. The association of cyclin D2 (B) and cyclin D3 (C) with the Aurka promoter (upper panels) or the Med18 promoter (bottom panels) in p27wt and
p27−/− MEFs was analyzed by ChIP using anti-cyclin D2, anti-cyclin D3 or without antibodies as a control. Results are the mean value ± SD of three
independent experiments and are relative to the control. Statistical analysis was performed using the Student’s t-test. *P < 0.05, **P< 0.01, ***P< 0.001.
Expression of Aurka and Med18 was altered in p27−/− and
p27CK- MEFs
Next, we studied the expression of Aurka and Med18 dur-
ing G1 in p27WT, p27−/− and p27CK− MEFs. The mRNA
levels of these two targets in p27WT -MEFs were low in G0,
intermediate in mid G1 and high in late G1 (Figure 5C). In-
terestingly, in p27−/− and p27CK− MEFs the levels of these
mRNAs in G0 were higher than in control cells confirm-
ing that p27 is acting as a transcriptional co-repressor and
that the integrity of the KID domain of p27 is necessary for
the transcriptional regulation of these genes. Similarly, in
late G1, the levels of mRNA for both genes were further in-
creased and were much higher than in control cells (Figure
5C). To analyze whether these mRNA changes, observed in
p27−/− and p27CK− MEFs, were due to increased transcrip-
tion we determined the levels of the primary non-spliced
transcript by qPCR using a primer of the first exon and an-
other one of the first intron. Results showed that the levels
of the primary non-spliced transcript were also elevated in
these cells (Figure 5D) indicating that p27 represses tran-
scription of these target genes in a Cdk-dependent manner.
This was supported by experiments showing that overex-
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Figure 5. The KID domain of p27 is essential for the proper regulation of Aurka and Med18 transcription. The association of cyclin D2 (A) and cyclin
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anti-cyclin D3 or without antibodies as a control. Results are the mean value ± SD of three independent experiments and are relative to the control. (C)
The levels of Aurka (upper panel) andMed18 (bottom panel) mRNAs were determined by qPCR at different times after proliferative activation in p27WT,
p27−/− and p27CK− MEFs. Results are the mean value± SE of three independent experiments and are relative to the control. (D) The Aurka (upper panel)
and Med18 (bottom panel) primary non-spliced transcript (PNS transcript) levels were determined by qPCR in p27WT, p27−/− and p27CK− MEFs. The
PNS transcript was determined using a primer of the first exon and another one of the first intron. Results are the mean value ± SD of three independent
experiments and are relative to the control. (E) p27−/− MEFs were infected with an empty vector or with a vector harboring full length p27WT. Levels
of p27 in these cells were determined by WB. (F) The levels of Aurka and Med18 mRNAs in p27−/− MEFs infected with a vector harboring full length
p27WT were determined by qPCR. Results are the mean value ± SD of three independent experiments and are relative to the control. Statistical analysis
was performed using the Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001.
6868 Nucleic Acids Research, 2015, Vol. 43, No. 14
pression of p27 in p27−/− cells reversed the increased levels
of both Aurka and Med18 mRNAs (Figure 5E).
The association of cyclin D1 and Cdk2 with the promoters of
p27 target genes is independent of p27
The observation that the association kinetics of cyclin D1
with the promoters of p27-TGswas quite different from that
of cyclin D2, D3, p27 and Cdk4 (Figures 2F, G and 4B),
suggested that the association of this cyclin with the pro-
moters could be independent of p27. These data also sug-
gested that cyclin D1 might play a role on the promoters
independently of Cdk4.
Thus, ChIP experiments were performed in p27WT and
p27−/− MEFs. Results revealed that in the absence of p27,
cyclin D1 remained associated with the promoters at early,
mid and late G1 (Figure 6A). These results indicated that
the association of cyclin D1 to the promoters was not in-
fluenced by p27, consistent with the different behavior of
cyclin D1 and p27 at promoters.
We next analyzed the interaction of p27 with Cdk2 in
NIH3T3 cells. We observed that it was low in G0, interme-
diate in G1 and high in late G1 (Supplementary Figure S1).
Analysis of the association of Cdk2 with promoters in these
cells revealed that it was low in G0 and in mid G1 but high
in late G1 (Figure 6B). Interestingly, the kinetics of the as-
sociation of cyclin D1 and Cdk2 with the promoters was
very similar (Figure 6C) suggesting that cyclinD1 andCdk2
can form complexes on the promoters. Finally, we studied
whether Cdk2 association with the promoters depended of
p27. For this, ChIP experiments were performed in p27WT
and p27−/− MEFs and although the amount of Cdk2 asso-
ciated with the promoters in p27−/− MEFs in late G1 was
slightly lower than in p27WT MEFs (Figure 6D), this reduc-
tion was not significant. This indicates that analogously to
what occurs with cyclin D1, p27 is not required to recruit
Cdk2 at promoters.
Association of cyclin D1 and Cdk2 with the promoters of tar-
get genes depends on p21
We explored the possibility that Cdk2 and cyclin D1 could
form a complex at promoters in late G1. We observed that
in NIH3T3 cells the levels of cyclin D1 were low in G0,
increased in mid G1 being highest in late G1 with an ac-
cumulation kinetics similar to that of p21 (Figure 7A). In
contrast, the levels of Cdk2 remained constant along cell
cycle. IP experiments in these cells showed that the inter-
action of cyclin D1 with Cdk2 and p21 was low in G0, in-
termediate in mid G1 and high in late G1 (Figure 7B). ChIP
analysis with anti-p21 antibodies revealed that in these cells,
the association of p21 with the Med18 promoter was rela-
tively constant along the cell cycle but showed slight fluc-
tuations in the association with the Aurka promoter (Fig-
ure 7C). In wild-type MEFs, the expression of cyclin D1,
Cdk2 and p21 and their interaction was similar to that ob-
served inNIH3T3 cells (Figure 7D). In p21−/−-MEFs levels
of Cdk2 remained constant along cell cycle, whereas those
of cyclin D1 were increasing similarly to control. However,
in p21−/−-MEFs the amount of cyclin D1 was significantly
lower than controls (Supplementary Figure S2) as also ob-
served in p27−/−-MEFs (Figure 3A). IP experiments using
anti-p21 antibodies revealed the interaction of this protein
with E2F4 and p130 (Figure 7E) indicating that similarly
to p27, p21 could associate to promoters via E2F4/p130
complexes. The possibility that p21 could be responsible of
cyclin D1 and Cdk2 recruitment on the promoters was an-
alyzed by ChIP performed in control and p21−/− MEFs.
ChIP analyses revealed that the association of Cdk2 (Fig-
ure 7F) and cyclin D1 (Figure 7G) with the promoters de-
pended on the presence of p21. To confirm the importance
of p21 in the regulation of the expression of the target genes,
we determined the levels of their mRNAs during G1 pro-
gression in control and p21−/− MEFs. We found that in
all cases the levels of both mRNAs in p21−/− -MEFs was
higher than in control MEFs (Figure 7H). These results re-
vealed that p21 behaves as a transcriptional repressor of
these target genes. This was further supported by experi-
ments showing that overexpression of p21 in p21KO cells re-
versed the increased levels of both Aurka and Med18 mR-
NAs (Figure 7I and J).
p27 and p21 collaborate in the repression of target genes
As p27 and p21 sequentially recruit different cyclin–cdk
complexes on the promoters of target genes we studied
whether the absence of these proteins would facilitate the
phosphorylation of p130, a well-known substrate of these
cyclin–cdk complexes that is present in the repressor com-
plexes operating on the promoters during the G1 phase of
the cell cycle. We analyzed the phosphorylation status of
p130 during G1 in control, p27 and p21 null MEFs, by us-
ing anti-phospho-p130 antibodies. As shown in Figure 8A
in control MEFs p130 started to be phosphorylated at 8 h
(mid G1) reaching a maximum at 18 h (late G1). Interest-
ingly, in both p27 or p21 null cells, p130 phosphorylation
was already high at time 0 that corresponds to G0. Then,
the levels of phosphorylation decreased and remained lower
(Figure 8A). These results revealed that p27 and p21 partic-
ipate in the regulation of transcription by controlling p130
phosphorylation.
The fact that p27 and p21 associate with the same pro-
moter regions and that they act as transcriptional repressors
of the same genes suggested that they can collaborate in the
regulation of gene expression. To confirm this possibility we
studied the expression of Aurka and Med18 in MEFs lack-
ing both p27 and p21 (DKO). As shown in Figure 8B, these
cells showed levels of mRNAof these two genes higher than
control cells but also higher than the single knock out cells
for p27 or p21 (Figures 5C and 7G). These results indicate
that p27 and p21 collaborate in a sequential manner in the
repression of transcription during G1.
DISCUSSION
Previous work described that p27 regulates transcription by
associating with p130/E2F4 complexes on the promoters
of specific p27-TGs (17). p27 is a structural component of
these repressor complexes that operate in quiescent cells and
in the G1 phase of the cell cycle to repress the expression of
genes encoding for proteins needed for DNA replication or
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Figure 6. The association of Cyclin D1 and Cdk2 with the promoters of target genes in late G1 is independent of p27. (A) The association of Cdk2 with
the Aurka (left panel) or the Med18 promoter (right panel) in p27WT and p27KO MEFs was analyzed by ChIP using anti-Cdk2 or without antibodies
as a control. Results are the mean value ± SD of three independent experiments and are relative to the control. (B) The association of Cdk2 with the
Aurka (upper panel) and the Med18 promoters (bottom panel) at different times after proliferative activation of NIH3T3 cells was analyzed by ChIP
using anti-Cdk2 or without antibodies as a control. Results are the mean value ± SD of three independent experiments and are relative to the control. (C)
Graphics showing the association kinetics of p27, cyclin D1, Cdk4 and Cdk2 with the Aurka (upper panel) and the Med18 promoters (bottom panel). (D)
The association of Cdk2 with the Aurka (left panel) and the Med18 promoters (right panel) in late G1 in p27WT and p27KO MEFs was analyzed by ChIP
using anti-Cdk2 or without antibodies as a control. Results are the mean value ± SD of three independent experiments and are relative to the control.
Statistical analysis was performed using the Student’s t-test. ns: not significant.
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Figure 7. p21 is required for the association of Cyclin D1 and Cdk2 with the promoters of target genes in late G1. (A) The levels of p21, cyclin D1 and
Cdk2 at different times after proliferative activation of NIH3T3 cells were determined by WB. (B) The interaction of cyclin D1 with p21 and Cdk2 in
NIH3T3 cells was analyzed by IP using anti-cyclin D1. IP using a non-specific IgG was used as a control. (C) The association of p21 with the Aurka (upper
panel) and the Med18 promoters (bottom panel) in NIH3T3 cells was analyzed by ChIP using anti-p21 or without antibodies as a control. Results are
the mean value ± SD of three independent experiments and are relative to the control. (D) The levels of p21, cyclin D1 and Cdk2 along the cell cycle in
p27WT MEFs were determined by WB (input). The interaction of p21 with cyclin D1 and Cdk2 was analyzed by IP using anti-p21. IP using a non-specific
IgG was used as a control. (E) The levels of E2F4 and p130 along the cell cycle in p27WT MEFs were determined by WB (input). The interaction of p21
with E2F4 and p130 at different times after proliferative activation was analyzed by IP using anti-p21. IP using a non-specific IgG was used as a control.
(F)The association of Cdk2 with the Aurka (upper panel) and the Med18 promoters (bottom panel) in late G1 in control and p21KO MEFs was analyzed
by ChIP using anti-Cdk2 or without antibodies as a control. Results are the mean value ± SD of three independent experiments and are relative to the
control. (G) The association of cyclin D1 with the Aurka (upper panel) and the Med18 promoters (bottom panel) in late G1 in control and p21KO MEFs
was analyzed by ChIP using anti-cyclin D1 or without antibodies as a control. Results are the mean value ± SD of three independent experiments and
are relative to the control. (H) The levels of Aurka (upper panel) and Med18 mRNAs (bottom panel) were determined by qPCR at different times after
proliferative activation in control and p21KO MEFs. Results are the mean value ± SD of three independent experiments and are relative to the control. (I)
p21−/− MEFs were infected with an empty vector or with a vector harboring full length p21WT. Levels of p21 in these cells were determined by WB. (F)
The levels of Aurka and Med18 mRNAs in p21−/− MEFs infected with a vector harboring full length p21WT were determined by qPCR. Results are the
mean value ± SD of three independent experiments and are relative to the control. Statistical analysis was performed using the Student’s t-test. *P< 0.05,
**P < 0.01, ***P < 0.001.
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mitosis (17). These p27-TGs include genes involved in cell
cycle progression, respiration, translation and RNA pro-
cessing and splicing (17). A recent report also revealed a role
of p27 in reprogramming mouse fibroblasts into pluripo-
tent stem cells by regulating the expression of Sox2 through
p130/E2F4 complexes (21). However, the specific role of
p27 in this regulation remained unknown.
p27 directly interacts with E2F4 and p130 via its carboxy-
terminal region (17). In contrast, its interaction with cyclins
and Cdks is mediated by the KID domain located at the
N-terminus of the protein (27). Thus, p27 could simulta-
neously associate with both cyclin–Cdks and p130/E2F4
repressor complexes on the promoters. As p130 is directly
phosphorylated by different Cdks (28), the interaction of
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p27with both types of complexes on the transcriptional reg-
ulatory regions of the genes would allow it to timely regulate
cyclin–Cdk activity and as a consequence p130 phosphory-
lation and transcription. We explored here this possibility.
We found that p27 associated with cyclins D2, D3 and
Cdk4 on the promoters of specific p27-TGs in quiescent fi-
broblasts (NIH3T3 andMEFs). This association wasmain-
tained till mid G1. The recruitment of cyclin D2/D3–Cdk4
was dependent on p27 because it was impaired in p27 null
cells. Since the mutant p27CK- also associated with the pro-
moters (17) the lack of binding of cyclins D2/D3 and Cdk4
at these specific sites in cells containing p27CK− confirmed
that p27 recruits cyclin D2/D3–Cdk4 at the promoters
through its KID domain.
Phosphorylation of p130 in mid G1 suggested that the
previously inactive cyclin D2/D3–Cdk4 complexes were ac-
tivated at that time. The mechanism responsible for this ac-
tivation on the promoters still remains unclear. However, an
attractive possibility is that they can be activated by phos-
phorylation of p27 on Y74 and Y88 by members of the Src
family of tyrosine kinases. Indeed, phosphorylation of p27
at these sites induces a conformational change that leads to
the partial activation of the Cdk despite the presence of p27
associated to cyclin–Cdk complexes (29). This possibility is
currently under study in our laboratory. Phosphorylation
of p130 by cyclin D2/D3–Cdk4 complexes primes it for its
subsequent phosphorylation by Cdk2.
Interestingly, we found that in late G1, p27, cyclin D2,
cyclin D3 and Cdk4 were no longer present at the promot-
ers, seemingly to be replaced by cyclin D1–Cdk2 complexes.
The recruitment of Cdk2 and cyclin D1 was independent of
p27 but required p21 since p21 null cells were unable to ac-
cumulate these proteins on the promoters in late G1. The
interaction of p21 with E2F4 and p130 observed by IP in-
dicates that the association of p21 to promoters could be
via E2F4/p130, similarly to p27. Thus, the sequential as-
sociation of cyclin D2/D3–Cdk4 in early–mid G1 and of
cyclin D1–Cdk2 complexes in late G1 at gene promoters is
driven by p27 and p21, respectively. By sequentially recruit-
ing these cyclin–Cdk complexes p27 and p21 play role in
transcriptional regulation of these genes (Figure 8C).
We observed that in the absence of p27, p130 phospho-
rylation was advanced and it was already phosphorylated
in early G1 (Figure 8A). This phosphorylation was con-
comitant with a significant increase of transcription of tar-
get genes also seen at that time (Figure 5C and D). These
results indicate that p27 defines the timing of p130 phos-
phorylation. In control cells p27 on the promoters keeps
Cdk4 inhibited till mid G1 when the shift from inactive to
active Cdk4 was produced. In contrast, in p27 null cells cy-
clin D2/D3–Cdk4 complexes were already active in early
G1 and despite they were not associated to the promoters
they phosphorylated p130 at that time by transiently inter-
acting with the substrate. We also report here a similar role
for p21. The fact that in the double p21/p27 null cells the
expression of target genes was much higher than in single
knock-out or control cells confirmed the collaborative role
of p27 and p21 in the regulation of transcription.
All these results clarify the role of p27 and p21 in the tran-
scriptional regulation of genes, repressed by p130/E2F4,
mainly involved in the regulation of DNA replication and
mitosis during cell cycle progression. We still do not know
whether this is a general mechanism operating in all the
p130/E2F4 regulated genes but the evidence that p27 and
p21 bind to E2F4/p130 suggest that it could be the case.
This collaboration also suggests that at least some transcrip-
tional programs regulated by p27might be the same as those
regulated by p21.
Overall, in cells undergoing a reversible cell cycle arrest,
the transcriptional repression machinery (p130/E2F4) re-
cruits CKIs at promoters which in turn can sequentially re-
cruit, while inhibiting them, cyclin–CDK complexes. The
assembly of these repressor/activator complexes on pro-
moters of genes needed for cell cycle progression offers a
versatile mechanism for the cell to rapidly resume a prolif-
erative state.
Increasing evidence indicate that p27 and p21 can act
both as tumor suppressors or oncogenes during tumor de-
velopment (29–33). Thus, results reported here revealing the
mechanisms by which both proteins collaborate in the reg-
ulation of transcription of genes involved in cell cycle pro-
gression might open new insights into the participation of
both proteins in tumorigenesis.
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